pillbase.ru

Silodosin

Active substance: silodosin

CAPSULE · SILODOSIN 8 mg/1

United StatesActive

Marketing holder: Ajanta Pharma USA Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 3
  • Silodosin Recordati
    silodosin
    EMEA/H/C/004964
    Recordati Ireland Ltd
  • Silodyx
    silodosin
    EMEA/H/C/001209
    Recordati Ireland Ltd
  • Urorec
    silodosin
    EMEA/H/C/001092
    Recordati Ireland Ltd
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4deb-7420-bd1f-dbae795b9b3f,01a1208c-8259-73bd-b7b0-f9d793f38fee,01a1208c-c8d5-7850-80d6-b528c326d477,01a1208d-8d11-7325-b812-d50d35fa42bf,01a1208d-bd59-7190-9b4c-6d36d19bae83;count=29 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
27241-145
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 27241-145 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 27241-145 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 27241-145 · Verified 2026-10-09 · open in source